Task: Answer the multiple-choice question.
Question: Which drug exhibits a -0.981% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCC(=O)Nc1nc(C)nc(C)c1C(C)=O
(b) COC(=O)CSc1nc(C2CC2)cc(C(F)(F)F)c1C#N
(c) CCN(CC)c1ccc2c(Nc3ccccc3)c(C=O)c(=O)oc2c1
(d) CC1(C)CC(=O)c2cc(OCC(=O)N3CCOCC3)ccc2O1
(e) Cc1c(C2C(C#N)=C(N)N(c3cccc([N+](=O)[O-])c3)C3=C2C(=O)CCC3)cnn1C
Answer: d. CC1(C)CC(=O)c2cc(OCC(=O)N3CCOCC3)ccc2O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)CC(=O)c2cc(OCC(=O)N3CCOCC3)ccc2O1
CC1(C)CC(=O)c2cc(OCC(=O)N3CCOCC3)ccc2O1
2,2-dimethyl-6-(2-morpholin-4-yl-2-oxoethoxy)-3H-chromen-4-one